The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Zhejiang University
Massachusetts General Hospital
Centre Georges Francois Leclerc
University of California, Davis
Jules Bordet Institute
Wuhan Ammunition Life-tech Co., Ltd
Revolution Medicines, Inc.
Imperial College London
Assistance Publique - Hôpitaux de Paris
TScan Therapeutics, Inc.
Shanghai Fengxian District Central Hospital
SpeciCare
Instituto do Cancer do Estado de São Paulo
Quantgene Inc.
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Sun Yat-sen University
Shenzhen Second People's Hospital
National Cancer Institute (NCI)
Meir Medical Center
Poniard Pharmaceuticals